News
IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...
GlobalData on MSN14h
Sarepta refuses to pull gene therapy despite FDA orderSarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the ...
Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...
Discover the transformative journey of anaesthesia, blending advanced technology with compassionate care for safer, more ...
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
The mental health industry watchdog Citizens Commission on Human Rights International (CCHR) is calling for sweeping reforms ...
Donnington pharmacy superintendent Nigel Dugmore said the online weight loss jab industry is a "ticking time bomb" due to the ...
GlobalData on MSN14h
Protocol flexibility and navigating the US geopolitical landscape in oncology clinical trialsIndustry experts have provided insight into how oncology clinical trials can be designed for success from the outset and rendered as patient-centric as possible.
A case that first appeared in a medical journal several years ago has recently resurfaced in the media, highlighting an ...
15h
Zacks Investment Research on MSNSRPT Down After Third Death in Muscular Dystrophy Gene Therapy ProgramShares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...
14h
Cycling Weekly on MSNCan you be body-positive and take Ozempic? I did — but for pain, not weight loss. Here’s whyBut, as my doctor explained, this was about the impact of carrying extra body weight on my joints. Given my lifelong struggles with dieting, he suggested there might be an underlying issue ...
John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results